CD200R1 promotes the development of murine γδ17 T cells
Journal of Leukocyte Biology · 2026
DOI: 10.1093/jleuko/qiag015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2026. Verfasst von Holly Linley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Science, Facult…. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, gamma-delta, Orexin Receptors, Th17 Cells. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manchester Collaborative Centre for Inflammation Research, University of Manchester, AstraZeneca.
Abstract (Originalsprache)
γδ T cells are enriched at barrier sites such as skin, gut, and lung, where they protect against cancer and infections, and promote healing. They detect diverse ligands in T-cell receptor–dependent or independent manners, producing large quantities of pro-inflammatory cytokines. γδ T cells develop in fetal thymi in temporally controlled waves where, unlike αβ T cells, many γδ T cells adopt their effector fate, becoming either IFN-γ or IL-17A producers (γδ17 T cells). CD200R1 suppresses myeloid cell activity but has also been shown to promote innate lymphoid cell IL-17A production, enhancing psoriasis-like skin inflammation. γδ17 T cells are potent IL-17A producers in skin. Therefore, the effect of CD200R1 on IL-17A production by γδ17 T cells was investigated using CD200R1KO mice. CD200R1 was revealed to promote IL-17A production by γδ T cells in skin and lymphoid organs. Although CD200R1 is not expressed by adult γδ T cells, it is expressed by immature developing γδ T cells in fetal thymus, where it supports the development of γδ17 T cells, enhancing γδ17 T-cell and RORγt+ γδ T-cell numbers in fetal thymic organ cultures. This identifies CD200R1 as an important novel regulator of γδ17 T-cell development in early life, a key process for ensuring immunity, particularly at barrier sites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Science, Faculty of Biology, Medicine and Health, University of Manchester, Mancheste…
- Biomedical and Life Sciences, Lancaster University, Bailrigg, Lancaster LA1 4YW, United Kingdom.
ORCID-Profile: Holly Linley, Shafqat Jaigirdar, Lucy Buckingham, Joshua Cox, Megan Priestley, Anna Hains, Amy Saunders
Förderung
- Manchester Collaborative Centre for Inflammation Research
- University of Manchester
- AstraZeneca
- GSK
- Wellcome Trust
- Royal Society
- Sir Henry Dale Fellowship
Zitieren
APA
Linley, H., Jaigirdar, S., Buckingham, L., Cox, J., Priestley, M., Hains, A., & Saunders, A. (2026). CD200R1 promotes the development of murine γδ17 T cells. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiag015
Vancouver
Linley H, Jaigirdar S, Buckingham L, Cox J, Priestley M, Hains A, et al. CD200R1 promotes the development of murine γδ17 T cells. Journal of Leukocyte Biology. 2026. doi:10.1093/jleuko/qiag015
BibTeX
@article{Linley2026,
author = {Linley, Holly and Jaigirdar, Shafqat and Buckingham, Lucy and Cox, Joshua and Priestley, Megan and Hains, Anna and Saunders, Amy},
title = {CD200R1 promotes the development of murine γδ17 T cells},
journal = {Journal of Leukocyte Biology},
year = {2026},
doi = {10.1093/jleuko/qiag015}
}
EUVIMED